Doctor profile · Federal record

Dr. Ryan Pham, D.O

Dermatology Physician (CMS: Dermatology) · Procedural Dermatology Physician · Burleson, TX

  • NPI 1407173230
  • Accepts Medicare
  • MIPS 75.0 / 100 · 2023
  • 16 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
621 Sw Johnson Ave, Suite C
Burleson, TX 760285833
(817) 766-7421
fax (817) 447-8100

Credentials & registration

NPPES · NUCC
NPI registered
May 2010 — 16 yrs on file
Profile last updated
November 28, 2017
Year of graduation
2010 — 16 yrs since
Specialty taxonomy
207N00000X — NUCC code
State license (1)
Texas #P1128

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1407173230. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
18,581
Distinct HCPCS
10
Medicare allowed
$365,925
HCPCS Description Services Patients Avg allowed
J7345 Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg 15,200 24 $2
99213 Established patient office or other outpatient visit, 20-29 minutes 645 394 $84
17003 Destruction of precancer skin growth, 2-14 growths 600 137 $6
99214 Established patient office or other outpatient visit, 30-39 minutes 381 260 $119
17000 Destruction of precancer skin growth, 1 growth 299 213 $49
17110 Destruction of skin growth, 1-14 growths 290 204 $106
11102 Biopsy of related skin growth, first growth 176 156 $85
99203 New patient office or other outpatient visit, 30-44 minutes 146 146 $104
96910 Therapy procedure using ultraviolet radiation with tar or petroleum jelly application 106 13 $111
99204 New patient office or other outpatient visit, 45-59 minutes 84 84 $153

In context: peer comparison

Among 1 peers in Burleson Dermatology Physician, average services per provider: 599. This provider delivers 31× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$6,627
Transactions
198
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Lilly USA, LLC 17 $1,826.78
Abbvie INC. 18 $744.87
Genzyme Corporation 18 $560.32
Leo Pharma INC. 13 $415.92
Ucb, INC. 23 $403.84
Mayne Pharma Commercial LLC 26 $381.24
Galderma Laboratories, L.P. 11 $300.36
Arcutis Biotherapeutics, INC. 16 $256.53
Amgen INC. 6 $233.68
E.R. Squibb & Sons, L.L.C. 5 $219.29
Dermavant Sciences, INC. 7 $218.21
Regeneron Healthcare Solutions, INC. 9 $181.00
Janssen Biotech, INC. 16 $173.66
Biofrontera INC. 10 $141.57
Ortho Dermatologics, A Division of Bausch Health US, LLC 3 $121.20

By nature of payment

Food and Beverage
$5,088
Travel and Lodging
$1,540

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
861
Patients
547
Total drug cost
$552,508
Drug Type Claims Patients Total cost
Clobetasol Propionate Generic 191 136 $10,799
Doxycycline Hyclate Generic 127 92 $4,928
Triamcinolone Acetonide Generic 121 95 $1,439
Ketoconazole Generic 117 67 $2,543
Mupirocin Generic 112 89 $1,183
Prednisone Generic 44 34 $150
Dupixent Pen (Dupilumab) Brand 29 0 $114,948
Betamethasone Dipropionate Generic 27 17 $2,088
Fluconazole Generic 20 17 $185
Ciclopirox Generic 17 0 $603

Frequently asked questions

Auto-generated from federal data
What is Dr. Ryan Pham's medical specialty?
Dr. Ryan Pham practices Dermatology Physician in Burleson, TX.
Where does Dr. Ryan Pham practice?
Dr. Ryan Pham practices at 621 Sw Johnson Ave, Burleson, TX 760285833. Office phone: 8177667421.
What is Dr. Ryan Pham's NPI?
Dr. Ryan Pham's National Provider Identifier (NPI) is 1407173230, issued by NPPES.
Does Dr. Ryan Pham accept Medicare assignment?
Yes. Dr. Ryan Pham accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Ryan Pham commonly perform?
Top Medicare-reported procedures in 2023: Aminolevulinic acid hcl for topical administration, 10% gel, 10 mg (HCPCS J7345); Established patient office or other outpatient visit (HCPCS 99213); Destruction of precancer skin growth, 2-14 growths (HCPCS 17003). Source: CMS Medicare Physician & Other Practitioners file.